Survivorship: Sexual dysfunction (female), version 1.2013 Journal Article


Authors: Denlinger, C. S.; Carlson, R. W.; Are, M.; Baker, K. S.; Davis, E.; Edge, S. B.; Friedman, D. L.; Goldman, M.; Jones, L.; King, A.; Kvale, E.; Langbaum, T. S.; Ligibel, J. A.; McCabe, M. S.; McVary, K. T.; Melisko, M.; Montoya, J. G.; Mooney, K.; Morgan, M. A.; O'Connor, T.; Paskett, E. D.; Raza, M.; Syrjala, K. L.; Urba, S. G.; Wakabayashi, M. T.; Zee, P.; McMillian, N.; Freedman-Cass, D.
Article Title: Survivorship: Sexual dysfunction (female), version 1.2013
Abstract: Cancer treatment, especially hormonal therapy and therapy directed toward the pelvis, can contribute to sexual problems, as can depression and anxiety, which are common in cancer survivors. Thus, sexual dysfunction is common in survivors and can cause increased distress and have a significant negative impact on quality of life. This section of the NCCN Guidelines for Survivorship provides screening, evaluation, and treatment recommendations for female sexual problems, including those related to sexual desire, arousal, orgasm, and pain. © JNCCN - Journal of the National Comprehensive Cancer Network.
Keywords: review; quality of life; pain; female sexual dysfunction; sexual arousal disorder; practice guideline; cancer survivor; cancer hormone therapy; depression; anxiety disorder; distress syndrome; orgasm disorder; human; female
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 12
Issue: 2
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2014-02-01
Start Page: 184
End Page: 192
Language: English
PROVIDER: scopus
PUBMED: 24586080
PMCID: PMC4465262
DOI/URL:
Notes: Export Date: 1 August 2014 -- Source: Scopus
Citation Impact
MSK Authors
  1. Mary McCabe
    108 McCabe
Related MSK Work